Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01309867 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Performance of Two Designs of Soft Toric Lenses
A NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 302
- Enrollment target
- 1
- Study location
NCT01309867: Completed NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
NCT01309867 is a NA study of Myopia that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 302 participants, above the 265-participant average among 90 other Myopia trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01309867, a NA study of Myopia, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 302 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to evaluate the product performance of the Bausch + Lomb toric investigational contact lenses compared to the currently marketed PureVision toric contact lenses.
Conditions Studied
Interventions
- DEVICE Investigational Toric Lens
- DEVICE PureVision Toric Lens
Study Locations (1)
New York
- Bausch & Lomb - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-04 |
| Phase | NA |
What the finished NCT01309867 record still lists
NCT01309867 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, above the 265-participant average among 90 other Myopia trials with a reported enrollment target (14% higher).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Investigational Toric Lens is the first listed.
NCT01309867 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01309867 about?
NCT01309867 is a clinical study titled "A Study to Evaluate the Performance of Two Designs of Soft Toric Lenses". The objective of the study is to evaluate the product performance of the Bausch + Lomb toric investigational contact lenses compared to the currently marketed PureVision toric contact lenses.
What is the current status of trial NCT01309867?
This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2010-12. Estimated completion is 2011-04.
What conditions does trial NCT01309867 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT01309867?
The interventions under investigation include: Investigational Toric Lens (DEVICE), PureVision Toric Lens (DEVICE).
Who is sponsoring clinical trial NCT01309867?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01309867 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01309867's enrollment target sits among peer trials
302 17th of 90 higher than 74 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia